1. Home
  2. SLN vs MNTK Comparison

SLN vs MNTK Comparison

Compare SLN & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • MNTK
  • Stock Information
  • Founded
  • SLN 1994
  • MNTK 1980
  • Country
  • SLN United Kingdom
  • MNTK United States
  • Employees
  • SLN N/A
  • MNTK N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • MNTK Natural Gas Distribution
  • Sector
  • SLN Health Care
  • MNTK Utilities
  • Exchange
  • SLN Nasdaq
  • MNTK Nasdaq
  • Market Cap
  • SLN 842.4M
  • MNTK 798.5M
  • IPO Year
  • SLN N/A
  • MNTK 2021
  • Fundamental
  • Price
  • SLN $12.70
  • MNTK $4.12
  • Analyst Decision
  • SLN Strong Buy
  • MNTK Hold
  • Analyst Count
  • SLN 4
  • MNTK 2
  • Target Price
  • SLN $61.50
  • MNTK $6.00
  • AVG Volume (30 Days)
  • SLN 184.3K
  • MNTK 214.6K
  • Earning Date
  • SLN 11-14-2024
  • MNTK 11-12-2024
  • Dividend Yield
  • SLN N/A
  • MNTK N/A
  • EPS Growth
  • SLN N/A
  • MNTK 42.11
  • EPS
  • SLN N/A
  • MNTK 0.16
  • Revenue
  • SLN $21,773,221.00
  • MNTK $194,849,000.00
  • Revenue This Year
  • SLN N/A
  • MNTK $22.46
  • Revenue Next Year
  • SLN $104.98
  • MNTK $22.06
  • P/E Ratio
  • SLN N/A
  • MNTK $25.47
  • Revenue Growth
  • SLN N/A
  • MNTK 9.63
  • 52 Week Low
  • SLN $8.94
  • MNTK $3.38
  • 52 Week High
  • SLN $27.72
  • MNTK $9.75
  • Technical
  • Relative Strength Index (RSI)
  • SLN 15.31
  • MNTK 29.06
  • Support Level
  • SLN $17.11
  • MNTK $4.00
  • Resistance Level
  • SLN $18.24
  • MNTK $5.78
  • Average True Range (ATR)
  • SLN 0.89
  • MNTK 0.42
  • MACD
  • SLN -0.49
  • MNTK -0.20
  • Stochastic Oscillator
  • SLN 1.06
  • MNTK 5.88

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.

About MNTK Montauk Renewables Inc.

Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.

Share on Social Networks: